LINISTAIN SLS— 510(k) K890984

Substantially Equivalent

Shandon, Inc.

FDA 510(k) clearance K890984 for LINISTAIN SLS, Substantially Equivalent on 1989-04-04. Applicant: Shandon, Inc..

Clearance details

Applicant: Shandon, Inc.
Product code: Code KIO
Advisory panel: Pathology
Date received: 1989-02-27
Decision date: 1989-04-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pittsburgh, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.